STW 5/Iberogast: Multi-Target-Wirkung bei funktioneller Dyspepsie und Reizdarmsyndrom

[1]  Karen L Jones,et al.  Effects of Iberogast® on Proximal Gastric Volume, Antropyloroduodenal Motility and Gastric Emptying in Healthy Men , 2007, The American Journal of Gastroenterology.

[2]  O. Kelber,et al.  Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  H. Allescher.  Functional dyspepsia--a multicausal disease and its therapy. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  O. Kelber,et al.  Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  S. Laufer,et al.  Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast). , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[6]  O. Kelber,et al.  Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  O. Kelber,et al.  Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  M. Schemann,et al.  Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[9]  O. Kelber,et al.  Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  H. Wagner,et al.  Multitarget therapy--the future of treatment for more than just functional dyspepsia. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[11]  G. Holtmann,et al.  Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  C. Cordes,et al.  Pharmaceutical prerequisites for a multi-target therapy. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  M. Storr,et al.  Iberogast und seine Bestandteile beeinflussen den peristaltischen Reflex am Dünndarm der Ratte , 2006 .

[14]  B. Göke,et al.  Herbal Extracts Modulate the Amplitude and Frequency of Slow Waves in Circular Smooth Muscle of Mouse Small Intestine , 2005, Digestion.

[15]  R. Saller,et al.  Meta‐analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast) , 2004, Alimentary pharmacology & therapeutics.

[16]  O. Kelber,et al.  The herbal preparation STW5 (lberogast®) has potent and region‐specific effects on gastric motility , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[17]  P. Enck,et al.  The herbal preparation STW 5 (Iberogast®) desensitizes intestinal afferents in the rat small intestine 1 , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[18]  G. Holtmann,et al.  Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast® , 2004, Wiener Medizinische Wochenschrift.

[19]  J. Tack.  Proximal gastric dysfunction in functional dyspepsia: Management options , 2004, Current treatment options in gastroenterology.

[20]  S S Cross,et al.  Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis , 2004, Gut.

[21]  E. Godehardt,et al.  Efficacy of a herbal preparation in patients with functional dyspepsia: A meta-analysis of double-blind, randomized, clinical trials , 2003, Advances in therapy.

[22]  M. Storr,et al.  Botulinumtoxin: Internistische Indikationen , 2002, Der Internist.

[23]  J. Melzer,et al.  Iberogast(r): Eine moderne phytotherapeutische Arzneimittelkombination zur Behandlung funktioneller Erkrankungen des Magen-Darm-Trakts (Dyspepsie, Colon irritabile) – von der Pflanzenheilkunde zur «Evidence Based Phytotherapy».Eine systematische Übersicht , 2002, Complementary Medicine Research.

[24]  I. Sassin,et al.  A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. , 2002, Zeitschrift fur Gastroenterologie.

[25]  J. Hartung,et al.  Treatment of Non-Ulcer Dyspepsia: Prokinetics Are Effective , 2002 .

[26]  A. Madisch,et al.  Ein Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie - Ergebnisse einer doppelblinden plazebokontrollierten Vergleichsstudie - , 2001 .

[27]  L. Mahran,et al.  Antiulcerogenic Effect of Some Gastrointestinally Acting Plant Extracts and their Combination , 2001, Arzneimittelforschung.

[28]  I. Sassin,et al.  [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study]. , 2001, Zeitschrift fur Gastroenterologie.

[29]  J. Stevens.  Treatment of irritable bowel syndrome. , 1981, British medical journal.